PHM:NYE-PulteGroup Inc. (USD)

EQUITY | Residential Construction | New York Stock Exchange

Last Closing

USD 112.74

Change

-1.46 (-1.28)%

Market Cap

USD 6.24B

Volume

1.33M

Analyst Target

USD 46.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

PulteGroup Inc is engaged in the homebuilding business. Its business includes the acquisition and development of land for residential purposes within the U.S. It is also engaged in mortgage banking operations.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-23 )

Largest Industry Peers for Residential Construction

Symbol Name Price(Change) Market Cap
DHI DR Horton Inc

N/A

USD 47.24B
LEN-B Lennar Corporation

N/A

USD 42.40B
LEN Lennar Corporation

N/A

USD 41.90B
NVR NVR Inc

N/A

USD 23.94B
TOL Toll Brothers Inc

N/A

USD 12.34B
MTH Meritage Corporation

N/A

USD 6.42B
IBP Installed Building Products In..

N/A

USD 6.08B
TMHC Taylor Morn Home

N/A

USD 6.00B
KBH KB Home

N/A

USD 5.40B
SKY Skyline Corporation

N/A

USD 3.86B

ETFs Containing PHM

ITB 8.01 % 0.42 %

N/A

N/A
NAIL Direxion Daily Homebuilde.. 5.75 % 0.99 %

N/A

USD 0.25B
PKB Invesco Dynamic Building .. 5.13 % 0.60 %

N/A

USD 0.32B
DBPE:F Xtrackers - LevDAX Daily .. 4.56 % 0.00 %

N/A

USD 0.05B
DBPE:XETRA Xtrackers LevDAX Daily Sw.. 4.56 % 0.00 %

N/A

USD 0.04B
XLDX:SW Xtrackers LevDAX Daily Sw.. 4.56 % 0.00 %

N/A

USD 411,075.38B
UDA:CA Caldwell U.S. Dividend Ad.. 4.18 % 0.00 %

N/A

CAD 4.80M
XHB SPDR® S&P Homebuilders E.. 3.82 % 0.35 %

N/A

USD 1.83B
ETLI:F Legal & General UCITS ETF.. 2.95 % 0.00 %

N/A

USD 0.02B
ETLI:XETRA L&G Pharma Breakthrough U.. 2.95 % 0.00 %

N/A

USD 0.02B
BIOT:SW L&G Pharma Breakthrough U.. 2.95 % 0.00 %

N/A

N/A
FXD First Trust Consumer Disc.. 1.48 % 0.64 %

N/A

USD 1.47B
AVMV Avantis U.S. Mid Cap Valu.. 1.17 % 0.00 %

N/A

USD 0.02B
JHMM John Hancock Multifactor .. 0.47 % 0.44 %

N/A

USD 3.69B
MUMC:CA Manulife Multifactor U.S... 0.46 % 0.55 %

N/A

CAD 8.26M
CLAW 0.00 % 0.95 %

N/A

N/A
FWDD 0.00 % 1.25 %

N/A

N/A
HOML 0.00 % 0.00 %

N/A

N/A
PWC 0.00 % 0.59 %

N/A

N/A
RCD 0.00 % 0.40 %

N/A

N/A
JAGG 0.00 % 0.07 %

N/A

N/A
MUMC-B:CA Manulife Multifactor U.S... 0.00 % 0.00 %

N/A

CAD 0.05B
WBIA 0.00 % 1.08 %

N/A

N/A
XLDX:LSE Xtrackers LevDAX Daily Sw.. 0.00 % 0.00 %

N/A

USD 0.04B
TQGM:CA TD Q Global Multifactor E.. 0.00 % 0.00 %

N/A

CAD 0.13B

Market Performance

  Market Performance vs. Industry/Classification (Residential Construction) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.22% 80% B- 75% C
Dividend Return 0.19% 9% A- 8% B-
Total Return 9.42% 80% B- 72% C
Trailing 12 Months  
Capital Gain 69.48% 85% B 95% A
Dividend Return 1.08% 27% F 13% F
Total Return 70.57% 85% B 94% A
Trailing 5 Years  
Capital Gain 251.00% 78% C+ 95% A
Dividend Return 9.03% 14% F 32% F
Total Return 260.02% 78% C+ 94% A
Average Annual (5 Year Horizon)  
Capital Gain 34.09% 55% F 91% A-
Dividend Return 35.41% 55% F 91% A-
Total Return 1.32% 55% F 32% F
Risk Return Profile  
Volatility (Standard Deviation) 46.27% 50% F 21% F
Risk Adjusted Return 76.53% 75% C 93% A
Market Capitalization 6.24B 84% B 91% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (Residential Construction) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 12.00 50% 78%
Price/Book Ratio 2.25 26% 38%
Price / Cash Flow Ratio 11.40 50% 34%
Price/Free Cash Flow Ratio 6.69 74% 58%
Management Effectiveness  
Return on Equity 27.30% 80% 89%
Return on Invested Capital -18.86% 11% 8%
Return on Assets 14.13% 95% 97%
Debt to Equity Ratio 26.27% 68% 76%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.